N4 Pharma PLC (N4P) — Strategic Asset Allocation Index
N4 Pharma PLC (N4P) has a Strategic Asset Allocation Index of 29.0% as of December 2016. Strategic assets (PP&E of GBX- plus long-term investments of GBX302.00K) total GBX302.00K, measured against net assets of GBX1.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check N4P cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
N4 Pharma PLC Strategic Asset Allocation Index (2004–2016)
This chart shows how N4 Pharma PLC's Strategic Asset Allocation Index has evolved across 13 annual periods from 2004 to 2016. As of December 2016, the index stands at 29.0%, representing strategic assets of GBX302.00K against net assets of GBX1.04 Million GBX. See N4P free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for N4 Pharma PLC (2004–2016)
The table below presents the year-by-year Strategic Asset Allocation Index for N4 Pharma PLC from 2004 to 2016, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see N4 Pharma PLC market capitalisation.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2016 | 29.0% | GBX302.00K | GBX- | GBX302.00K | GBX1.04 Million | ▲ +21.2 pp |
| 2015 | 7.8% | GBX50.00K | GBX- | GBX50.00K | GBX641.00K | ▼ -51.3 pp |
| 2014 | 59.1% | GBX616.00K | GBX616.00K | GBX- | GBX1.04 Million | ▲ +19.5 pp |
| 2013 | 39.6% | GBX1.37 Million | GBX1.37 Million | GBX- | GBX3.45 Million | ▼ -6.8 pp |
| 2012 | 46.4% | GBX1.67 Million | GBX1.67 Million | GBX- | GBX3.60 Million | ▼ -15.1 pp |
| 2011 | 61.5% | GBX2.15 Million | GBX2.15 Million | GBX- | GBX3.49 Million | ▲ +20.1 pp |
| 2010 | 41.4% | GBX1.22 Million | GBX1.22 Million | GBX- | GBX2.96 Million | ▼ -3.2 pp |
| 2009 | 44.6% | GBX1.17 Million | GBX1.17 Million | GBX- | GBX2.63 Million | ▲ +1.1 pp |
| 2008 | 43.5% | GBX621.00K | GBX621.00K | GBX- | GBX1.43 Million | ▲ +33.2 pp |
| 2007 | 10.3% | GBX120.00K | GBX120.00K | GBX- | GBX1.17 Million | ▼ -3.8 pp |
| 2006 | 14.1% | GBX127.00K | GBX127.00K | GBX- | GBX903.00K | ▼ -992.9 pp |
| 2005 | 1007.0% | GBX3.91 Million | GBX3.91 Million | GBX- | GBX388.00K | ▲ +514.0 pp |
| 2004 | 492.9% | GBX4.12 Million | GBX4.12 Million | GBX- | GBX836.00K | — |